Genome-wide end-sequenced BAC resources for the NOD/MrkTac☆ and NOD/ShiLtJ☆☆ mouse genomes

Non-obese diabetic (NOD) mice spontaneously develop type 1 diabetes (T1D) due to the progressive loss of insulin-secreting β-cells by an autoimmune driven process. NOD mice represent a valuable tool for studying the genetics of T1D and for evaluating therapeutic interventions. Here we describe the development and characterization by end-sequencing of bacterial artificial chromosome (BAC) libraries derived from NOD/MrkTac (DIL NOD) and NOD/ShiLtJ (CHORI-29), two commonly used NOD substrains. The DIL NOD library is composed of 196,032 BACs and the CHORI-29 library is composed of 110,976 BACs. The average depth of genome coverage of the DIL NOD library, estimated from mapping the BAC end-sequences to the reference mouse genome sequence, was 7.1-fold across the autosomes and 6.6-fold across the X chromosome. Clones from this library have an average insert size of 150 kb and map to over 95.6% of the reference mouse genome assembly (NCBIm37), covering 98.8% of Ensembl mouse genes. By the same metric, the CHORI-29 library has an average depth over the autosomes of 5.0-fold and 2.8-fold coverage of the X chromosome, the reduced X chromosome coverage being due to the use of a male donor for this library. Clones from this library have an average insert size of 205 kb and map to 93.9% of the reference mouse genome assembly, covering 95.7% of Ensembl genes. We have identified and validated 191,841 single nucleotide polymorphisms (SNPs) for DIL NOD and 114,380 SNPs for CHORI-29. In total we generated 229,736,133 bp of sequence for the DIL NOD and 121,963,211 bp for the CHORI-29. These BAC libraries represent a powerful resource for functional studies, such as gene targeting in NOD embryonic stem (ES) cell lines, and for sequencing and mapping experiments.

[1]  J. Rogers,et al.  A genome-wide, end-sequenced 129Sv BAC library resource for targeting vector construction. , 2005, Genomics.

[2]  Shaying Zhao,et al.  A comprehensive BAC resource , 2001, Nucleic Acids Res..

[3]  Oliver S Burren,et al.  Gene-gene interactions in the NOD mouse model of type 1 diabetes. , 2008, Advances in immunology.

[4]  J. Mullikin,et al.  SSAHA: a fast search method for large DNA databases. , 2001, Genome research.

[5]  Andrew M. Jenkinson,et al.  Ensembl 2009 , 2008, Nucleic Acids Res..

[6]  Angelo J. Canty,et al.  Sex-Specific Effect of Insulin-Dependent Diabetes 4 on Regulation of Diabetes Pathogenesis in the Nonobese Diabetic Mouse1 , 2005, The Journal of Immunology.

[7]  Parvaneh Saeedi,et al.  A physical map of the mouse genome , 2002, Nature.

[8]  J. Nichols,et al.  Validated germline-competent embryonic stem cell lines from nonobese diabetic mice , 2009, Nature Medicine.

[9]  E. Leiter.  The NOD Mouse: A Model for Insulin‐Dependent Diabetes Mellitus , 1997, Current protocols in immunology.

[10]  Y. Tochino,et al.  Breeding of a non-obese, diabetic strain of mice. , 1980, Jikken dobutsu. Experimental animals.

[11]  Toshio Kojima,et al.  Contribution of Asian mouse subspecies Mus musculus molossinus to genomic constitution of strain C57BL/6J, as defined by BAC-end sequence-SNP analysis. , 2004, Genome research.

[12]  A. Berns,et al.  Highly efficient gene targeting in embryonic stem cells through homologous recombination with isogenic DNA constructs. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[13]  J. Todd,et al.  Genetic control of autoimmune diabetes in the NOD mouse. , 1995, Annual review of immunology.

[14]  Nancy F. Hansen,et al.  Accurate Whole Human Genome Sequencing using Reversible Terminator Chemistry , 2008, Nature.

[15]  Mark S. Anderson,et al.  THE NOD MOUSE: AM odel ofImmune Dysregulation , 2005 .

[16]  Edwin Liu,et al.  Type 1 diabetes: recent developments , 2004, BMJ : British Medical Journal.

[17]  P. D. de Jong,et al.  Bacterial artificial chromosome libraries for mouse sequencing and functional analysis. , 2000, Genome research.

[18]  Anne-Marie Chang,et al.  Functional Identification of the Mouse Circadian Clock Gene by Transgenic BAC Rescue , 1997, Cell.

[19]  J. Todd,et al.  HLA DR-DQ Haplotypes and Genotypes and Type 1 Diabetes Risk , 2008, Diabetes.

[20]  L. Hillier,et al.  Automated sequence preprocessing in a large-scale sequencing environment. , 1998, Genome research.

[21]  M. Atkinson,et al.  The NOD mouse model of type 1 diabetes: As good as it gets? , 1999, Nature Medicine.

[22]  Sean R. Eddy,et al.  The Distributed Annotation System , 2001, BMC Bioinformatics.

[23]  J. Todd,et al.  From genome to aetiology in a multifactorial disease, type 1 diabetes , 1999, BioEssays : news and reviews in molecular, cellular and developmental biology.

[24]  P. D. de Jong,et al.  A modular, positive selection bacterial artificial chromosome vector with multiple cloning sites. , 1999, Genomics.

[25]  C. Lengner,et al.  Metastable pluripotent states in NOD-mouse-derived ESCs. , 2009, Cell stem cell.